AI in Drug Development: Moving Beyond Early Use Cases
As new rules take hold, what does “good AI practice” look like in drug development?
False
Advertisement
Related Content
Industry News
Future of Pharma
Research News
Building a Pre-Disease Data Map
October 7, 2026
2 min read
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear
Supply Chain
Future of Pharma
Business & Trends
The Resilience Prescription
October 2, 2026
5 min read
We asked the 2026 Power List how the pharmaceutical industry can prepare for geopolitical, economic, regulatory, and scientific uncertainty
Development & Clinical
Future of Pharma
How Companion Diagnostics Can Support Targeted Drug Launches
September 29, 2026
5 min read
Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval
Future of Pharma
Regulation & Standards
What Do Scientists Want from AI?
September 14, 2026
5 min read
Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place